Skip to content

Comparison of retropetoneal laparoscopic nephrectomy and transperitoneal laparoscopic radical nephrectomy in the treatment of T1~T3aN0M0 renal cell carcinoma

A multi-center, randomized, parallel-group, controlled trial of retropetoneal laparoscopic radical nephrectomy and transperitoneal laparoscopic radical nephrectomy in the treatment of T1~T3aN0M0 renal cell carcinoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014431
Enrollment
Unknown
Registered
2018-01-13
Start date
2018-02-01
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Carcinoma

Interventions

1:peritoneal laparoscopic radical nephrectomy
2:retroperitoneal laparoscopic radical nephrectomy

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years male and female; 2. Limitations of renal cell carcinoma (staging T1 ~ T3aN0M0), but should be excluded except for small renal cell carcinoma; 3. Patients and their families have signed informed consent; 4. no previous history of other malignant tumors.

Exclusion criteria

Exclusion criteria: 1. The tumor has been invading the renal vein and inferior vena cava; 2. Do not have capable or behavioral capacity is limited; 3. Preoperative routine chest X-ray and pelvic enhancement CT examination revealed that there were no radical surgical procedures or intraoperative exploration in distant metastasis. 4. Have other serious diseases, including cardiovascular, respiratory, kidney, or liver diseases, and combine to control patients with poor hypertension and diabetes; 5. Pregnant and lactating women; 6. History of abdominal surgery or retroperitoneal surgery or surgery history; 7. Preoperative history of chemotherapy; 8. Severe coagulation function abnormal electrolyte balance disorder hypoproteinemia was corrected without obvious improvement; 9. Have narcotic contraindications for the anaphylaxis of narcotic drugs; 10. The researcher considers that there are any other circumstances that are not suitable for participating in the test.

Design outcomes

Primary

MeasureTime frame
Lenght of peritoneal laparoscopic surgery;

Secondary

MeasureTime frame
Haemorrhage;Hospital stay after surgery;Cost;Physical state;OS;

Countries

China

Contacts

Public ContactShang Panfeng

Lanzhou University Second Hospital

shangpf@lzu.edu.cn+86 13919785295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026